Strategic IP for Oligonucleotide Therapeutics: Maximizing Innovation Value
Date: August 28, 2025 Time: 11-12pm EDT / 5-6pm CEST Title: Strategic IP for Oligonucleotide Therapeutics: ...
The importance of involving patients in therapy development; Lessons learned from Duchenne exon skipping
Date: August 21, 2025 Time: 11-12pm EDT / 5-6pm CEST Title: The importance of involving patients ...
Perspectives on Oligonucleotide Therapeutics: A discussion with Rebecca Miles, incoming president of OTS
Date: June 12, 2025 Time: 11-12pm EDT / 5-6pm CEST Title: Perspectives on Oligonucleotide Therapeutics: A ...
